Nestlé will acquire Pfizer Nutrition for US$11.85 billion to enhance its position in global infant nutrition. Announced on 23 April, the acquisition aims to complement Nestlé’s existing model for growth, global presence and margins, as well as the group's earnings per share in the full first year. “Pfizer Nutrition is an excellent strategic fit and this acquisition underlines our commitment to be the world's leading nutrition, health and wellness company,” says Nestlé CEO Paul Bulcke says. “The combined entities will enable us to deepen our engagement with consumers, offering them a wider choice of nutritious food to ensure their children make a healthy start to a healthy life.” Nestlé estimates the acquired business' 2012 sales at USD 2.4 billion. Pfizer Nutrition is a high-growth infant nutrition business with strong brands and product portfolio. Eighty five per cent of its sales are in emerging markets, many of them with fast-growing populations. The new acquisition will build on Nestlé’s existing infant nutrition business and is subject to regulatory approval. Image supplied by Nestlé.